Riva Medical Research Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.09 Cr
- Revenue Growth 21.45%
- Profit Growth 8.11%
- Ebitda 9.46%
- Net Worth 46.59%
- Total Assets 38.75%
About Riva Medical Research
Riva Medical Research Private Limited (RMRPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 April 2018 (Six years and ten months 10 days old ). Its registered office is in Valsad, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.09 Cr.
Rekha Srhivastawa and Rajesh Shrivastava serve as directors at the Company.
Company Details
- Location
Valsad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85300GJ2018PTC101799
- Company No.
101799
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Apr 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Riva Medical Research?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rekha Srhivastawa  | Director | 12-Apr-2018 | Current |
| Rajesh Shrivastava | Director | 12-Apr-2018 | Current |
Financial Performance of Riva Medical Research.
Riva Medical Research Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.45% increase. The company also saw a slight improvement in profitability, with a 8.11% increase in profit. The company's net worth Soared by an impressive increase of 46.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Riva Medical Research?
Unlock access to Riva Medical Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹10.90 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 1.09 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Mar 2023 | State Bank Of India | ₹1.09 Cr | Open |
How Many Employees Work at Riva Medical Research?
Riva Medical Research has a workforce of 32 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Riva Medical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Riva Medical Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.